N itric oxide is a putative neurotransmitter in the brain and peripheral nervous system and an important mediator of vascular homeostasis and blood flow. 1 It is generated by 3 different types of NO synthase (NOS), the constitutive calcium/calmodulin-dependent neuronal and endothelial isoforms and the inducible calcium-independent isoform. 2 NO produced by endothelial NOS (eNOS) reduces apoptosis and confers protection against stroke, whereas pathological concentrations of NO from inducible NOS and neuronal NOS (nNOS) induce apoptosis and are neurotoxic. 3, 4 Inhibition of eNOS activity decreases cerebral blood flow and promotes tissue damage after focal ischemia. 5 Increase in eNOS protein levels after transient or permanent focal ischemia and global cerebral ischemia has been reported in infarcted areas, 6 -8 but mechanisms of postischemic modification of eNOS in terms of the upregulation remain to be clarified. Several recent studies have demonstrated that insulin, estrogen, and vascular endothelial growth factor (VEGF) cause eNOS phosphorylation and result in endothelial NO release through the phosphatidylinositol 3Ј-kinase (PI3-kinase)-Akt-dependent pathway. However, to our knowledge, eNOS phosphorylation after cerebral ischemia has not been identified in vivo.
Therefore, the aim of the present study was to evaluate phosphorylated eNOS levels in the cortex after forebrain ischemia in vivo using Western blot analysis and immunohistochemical methods. We also examined by ELISA the expression of VEGF as a regulator of eNOS. 9
Materials and Methods

Materials
␤-Nicotinamide adenine dinucleotide phosphate (NADPH) was purchased from Oriental Yeast, and 2Ј-5Ј-ADP-agarose and other chemicals, unless otherwise specified, were from Sigma.
Forebrain Ischemic Model
All experiments were performed in accordance with guidelines for the care and use of laboratory animals in the physiological sciences as approved by the Physiological Society of Japan.
We adopted a forebrain ischemia model by Smith et al 10 that consistently gives flow rates of Ͻ5% of control in cortex. 11 Anesthesia was induced in male Sprague-Dawley rats (350 to 400 g, Chubu Kagaku Shizai Ltd, Nagoya, Japan) using methohexital sodium (50 mg/kg IP). Animals were then intubated and ventilated with 1.0% halothane in an oxygen/nitrous oxide (30%/70%) gas mixture. Temperature was monitored with a rectal probe and maintained between 36.5 and 37.5°C with a heating pad and lamp. The right femoral artery and vein were catheterized with polyethylene tubing (PE-50) to allow blood sampling and the monitoring of arterial blood pressure during ischemia. Arterial blood gases were examined 5 minutes before ischemia induction and 15 minutes after blood reperfusion. Heparin (150 IU/kg) was administered intravenously before induction of ischemia. Blood was withdrawn from the femoral vein catheter to cause hypotension with a mean arterial blood pressure of 50 mm Hg, and both carotid arteries were clamped. At the end of the 15-minute ischemia period, clamps were removed, blood was reinfused through the femoral vein catheter, and all wounds were sutured.
Brain samples were collected at the end of the 15-minute ischemia, as well as after 0.5, 2, 6, 12, and 24 hours of reperfusion. Rats with all surgical procedures, but without carotid occlusion and hypotension, were used as controls. Because there are many more microvessels in cortex than in hippocampus, we used cortex rather than hippocampus for tissue analysis in our forebrain ischemia model. The bilateral cortices adjacent to the hippocampus were immediately isolated on ice, frozen in liquid nitrogen, and kept at Ϫ80°C until analysis.
Sample Preparation for Western Blot Analysis
Samples were prepared from 4 different animals in each group. Brain tissues were homogenized using a homogenizer in 10 volumes of homogenization buffer containing 50 mmol/L Tris base/HCl, pH 7.5, 0.1 mmol/L dithiothreitol, 0.2 mmol/L EDTA, 0.2 mmol/L EGTA, 0.2 mmol/L phenylmethylsulfonyl fluoride (PMSF), 1.25 g/mL pepstatin A, 0.2 g/mL aprotinin, 0.2 g/mL leupeptin, 5 nmol/L tetrahydrobiopterin, 1 mmol/L sodium orthovanadate, 50 mmol/L sodium fluoride, 2 mmol/L sodium pyrophosphate, and 1% Nonidet P-40 (NP-40). Homogenates were then centrifuged at 15 000 rpm at 4°C for 10 minutes. Protein concentrations of the supernatants were determined by the Bradford method using BSA as the standard. Supernatant fractions were applied as crude fractions.
For preparation of the NOS fraction, the enzyme was partially purified with 2Ј-5Ј-ADP-agarose, as described previously. 12 
Western Blotting Analysis
Extract samples and 25 g of crude samples were subjected to 7.5% SDS-PAGE, and proteins were transferred to polyvinylidene difluoride (PVDF) membranes and incubated with primary polyclonal antibodies against Ser 1177 -phosphorylated eNOS (Cell Signaling Technology, Beverly, Mass) at a dilution of 1:200, Ser 473 -phosphorylated Akt (Cell Signaling Technology, Beverly, Mass) at a dilution of 1:500, or actin (Sigma, St Louis, Mo) at a dilution of 1:200 for 45 minutes at room temperature. Membranes were then incubated with secondary antibodies, which were visualized using an enhanced chemiluminescence (ECL) or ECL plus Western blotting detection system (Amersham). Phospho-eNOS and Akt immunoblots were stripped from PVDF membranes and reblotted with primary monoclonal eNOS (Transduction Laboratories, Lexington, Ky) at a dilution of 1:2000 and polyclonal Akt (Cell Signaling Technology, Beverly, Mass) at a dilution of 1:500 for 45 minutes at room temperature. Finally, membranes were developed with the ECL system. eNOS immunoblots were stripped again and reblotted with primary monoclonal nNOS (Transduction Laboratories, Lexington, Ky) at a dilution of 1:3000 and developed with the ECL system. Band intensities were quantitated by densitometric scanning using the NIH IMAGE program.
VEGF Immunoassay
Cortical tissue lysates were prepared at different times after cerebral ischemia. The homogenizing lysis buffer contained 10 mmol/L Tris base/HCl, pH 7.5, 1 mmol/L EDTA, 0.1 mol/L sodium chloride, 100 g/mL PMSF, 1 g/mL aprotinin, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS; homogenates were centrifuged in a microcentrifuge for 10 minutes, and supernatants were collected. Concentrations of VEGF in the lysates were quantitated using a commercially available VEGF ELISA kit (Quantikine M; R&D Systems) and the protein concentration by the Bradford method.
Immunohistochemistry
Rats subjected to a 15-minute ischemia followed by a 12-hour reperfusion were perfused with ice-cold 200 mL 4% paraformaldehyde in 0.1 mol/L sodium phosphate, pH 7.4. Serial coronal cryostat sections (10 m) were stained according to the avidin-biotinylated peroxidase complex (ABC) technique at room temperature. The staining sequence was as follows: 2% goat serum for 30 minutes; primary polyclonal antibodies (Cell Signaling Technology, Beverly, Mass) against phospho-Ser 1177 eNOS at a dilution of 1:75, phosphoSer 437 Akt at a dilution of 1:60, Akt at a dilution of 1:180, and monoclonal antibodies (Transduction Laboratories, Lexington, Ky) against eNOS at a dilution of 1:500; biotinylated anti-rabbit or mouse IgG for 1 hour; and ABC for 1 hour. Sera for the blocking step, biotinylated antibodies, and ABC were purchased from Vector Laboratories. Reaction products were developed by incubation in 0.05% 3,3Ј-diaminobenzidine tetrachloride and 0.01% H 2 O 2 in 50 mmol/L Tris-HCl, pH 7.5, for 10 minutes. Rats with all surgical procedures, but without carotid occlusion and hypotension, were used as controls.
Statistical Analysis
Data are expressed as meanϮSE values. Statistical analyses were performed by 1-way ANOVA followed by Fisher post hoc test. Statistical significance was concluded at the PϽ0.05 level.
Results
Physiological Parameters
Major physiological parameters for the animals were unaltered. No significant changes in mean arterial blood pressure, temperature, or arterial blood gas data were detected among any of the experimental groups by repeated-measure ANOVA (Table) .
Effects of Ischemia on Phosphorylation of Akt at Ser 473
We first examined the levels of phosphorylated Akt at Ser 473 in crude fractions after transient ischemia. A 6-fold enhancement was evident after a 30-minute reperfusion, relative to nonischemic control samples (Figure 1 ). Even after a 2-hour reperfusion, Akt phosphorylation was significant. Equal levels of actin and Akt were detected in crude fractions even after reperfusion, indicating that similar amounts of proteins were loaded and that an ischemic episode modulates Akt primarily through phosphorylation at Ser. 473 
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Serial Change in VEGF Level After Forebrain Ischemia
Use of a specific ELISA demonstrated the mean VEGF protein concentration in the brain cortex to be 578Ϯ16 pg VEGF per gram total protein (nϭ4). VEGF protein levels were significantly increased Յ1.5-fold between 6 and 24 hours after reperfusion ( Figure 2 ).
Effects of Ischemia on Phosphorylation of eNOS at Ser 1177
We measured the densitometric ratio of phospho-eNOS relative to whole eNOS expressions in the same PVDF membrane. Transient ischemia resulted in a 3-fold enhancement in phosphorylation of eNOS at Ser 1177 after a 6-hour reperfusion compared with control, with significant persistence until 24 hours after reperfusion (Figure 3 ).
Phosphorylation of eNOS and Akt After Transient Ischemia
After a 12-hour reperfusion, immunoreactivity against eNOS was apparent in the endothelial cells of microvessels without any remarkable change from the control case ( Figure 4A and 4B) . No immunoreactivity of phospho-Ser 1177 eNOS was detected in control rat cortex, whereas intense immunoreactivity was observed in the endothelial cells of microvessels after a 12-hour reperfusion ( Figure 4C and 4D) . Akt was detected mainly in the neurons in the cortex but weakly observed in the endothelial cells of microvessels ( Figure 4E and 4F) . Phospho-Ser 437 Akt was observed not only in the neurons but also in the endothelium after a 12-hour reperfusion ( Figure 4H) .
Discussion
The present study demonstrated, for the first time to our knowledge, significant increase in phosphorylated eNOS at Ser 1177 from 6 hours after forebrain cerebral ischemia in vivo. Upregulation of nNOS after cerebral ischemia has been reported, 13, 14 but our data showed that levels of nNOS in NOS fractions after forebrain ischemia did not change significantly for at least the first 24 hours by immunoblot analysis, whereas the amount of eNOS phosphorylated at Ser 1177 became significantly elevated. This difference may come from the methods we used. We partially purified NOS by using ADP agarose affinity chromatography to detect the level of phosphorylation of eNOS. Huang et al 15 reported that eNOS knockout mice exhibit larger brain infarcts after cerebral ischemia than their wild-type counterparts, and NO from endothelium may be protective in cases of stroke. 2, 16 It inhibits platelet aggregation in capillaries, 17 leukocyte infiltration into the parenchyma, 18 and smooth muscle cell proliferation, 19 although NO generated by nNOS may lead to neurotoxicity after cerebral ischemia. 2, 5, 16, 20 It was shown recently that Ser 847 phosphorylation of nNOS, leading to a reduction of its enzyme activity in rat hippocampus, might be a novel tolerance mechanism in hippocampal neurons. 11 NO production from phosphorylated eNOS at Ser 1177 may play an important role in protecting brain tissue by augmenting regional cerebral blood flow after cerebral ischemia.
VEGF is a major regulator of endothelial cell proliferation, angiogenesis, and vascular permeability. 21 Our present results indicate that it is significantly increased after forebrain ischemia, consistent with the previous finding of induction of VEGF and hypoxia-inducible factor-1␣ after global ischemia. 22 VEGF is expressed not only in vascular endothelial cells, 22, 23 but also in cytoplasm of pyramidal neurons and astrocytes after cerebral ischemia. [22] [23] [24] [25] [26] Because the 2 receptors for VEGF, flt and flk, are expressed exclusively in endothelial cells, 25, 27 the signal transduction from VEGF might be expected to be more smooth in the endothelium than neurons.
Our data showed a chronological parallel between increase of VEGF and phosphorylation of eNOS. The factor has been shown that VEGF induces release of NO from vascular endothelial cells 9, 28, 29 and also has direct neurotrophic effects with stimulation of axonal outgrowth and increase of neuron survival. 30 In fact, Hayashi et al 31 reported reduction of ischemic brain damage by application of VEGF after middle cerebral artery occlusion in vivo. Gerber et al 32 reported that VEGF regulates endothelial cell survival through the PI3-kinase/Akt signal transduction pathway. Akt was activated in the endothelium in hippocampus after transient forebrain ischemia. 33 Immunohistochemistry revealed Akt phosphorylation in endothelial cells after 12-hour reperfusion, which may correlated with the phosphorylation of eNOS in our model.
Recent reports have provided evidence that Ser 1177 phosphorylation activates eNOS, whereas Thr 495 phosphorylation inhibits activity. This regulation of eNOS involves phosphatases and multiple protein kinases, including Akt, and the AMP-activated protein kinase. 34 -37 The serine/threonine kinase Akt, also known as protein kinase B, enhances survival with cerebral ischemia through a PI3-kinase-dependent signaling pathway. Akt phosphorylation induced by cerebral ischemia is detected not only in hippocampus but also cerebral cortex after cerebral ischemia occurring within 4 hours of reperfusion, in agreement with our results. Phosphorylation of Akt immediately after ischemia has been found to be mainly localized in astrocytes or neurons in cerebral cortex; 38, 39 our findings suggest that this is not directly correlated with phosphorylation of eNOS.
In conclusion, our results show that eNOS is phosphorylated in endothelial cells of microvessels in the cortex within 6 hours after forebrain ischemia. This could increase enzyme activity and production of NO and thus contribute to regulation of cerebral blood flow after cerebral ischemia. Further studies are now needed to explore the molecular mechanisms that regulate induction of VEGF and modification of eNOS in the ischemic brain in vivo.
